Literature DB >> 27317014

Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care.

Nghi B Ha1, Katherine Yang1, Sarah Hanigan1, Brian Kurtz1, Michael P Dorsch1, Hannah Mak2, Jerod Nagel3.   

Abstract

BACKGROUND: Drug-drug interactions (DDIs) with warfarin and antimicrobial agents are a common cause of international normalized ratio (INR) instability, which can affect the risk for bleeding and thrombotic events.
OBJECTIVE: The purpose of this study was to assess the impact of a comprehensive guideline for the management of warfarin-antimicrobial DDIs across transitions of care. The guideline emphasizes improving identification of significant antimicrobial-warfarin DDIs during hospitalization, empirical warfarin dose modification based on DDI and baseline INR, patient education, documentation of the DDI, communication with outpatient providers regarding the DDI and anticipated antimicrobial stop date, and warfarin dose adjustment on discontinuation of antimicrobial.
METHODS: This retrospective, single-center, quasiexperimental, pre-post study compared end points 3 months before and after guideline implementation. The primary outcome was time within therapeutic range (TTR).
RESULTS: The study included 78 preguideline and 31 postguideline patients; baseline characteristics were similar between groups. Implementation of the guideline resulted in greater in-hospital TTR (72% vs 50%, P = 0.04) and improved TTR across transition of care (70% vs 46%, P = 0.01). Documentation of DDI in the pharmacy anticoagulation discharge summary significantly improved in the postguideline group (40% vs 14%, P = 0.02) and numerically improved within the daily pharmacy progress notes (94% vs 82%, P = 0.13). The implementation of the guideline was associated with a nonsignificant, numerical reduction in bleeding events compared with the preguideline group (0 vs 4 events, P = 0.11).
CONCLUSION: This single-center approach to optimize the comprehensive management of significant antimicrobial-warfarin DDIs resulted in improved communication with outpatient providers and improved INR TTR.
© The Author(s) 2016.

Entities:  

Keywords:  antibiotics; anticoagulation; clinical practice; drug interactions; warfarin

Mesh:

Substances:

Year:  2016        PMID: 27317014     DOI: 10.1177/1060028016653765

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

Review 1.  Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors:  Sara R Vazquez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants.

Authors:  Xue Feng; Usha Sambamoorthi; Kim Innes; Gregory Castelli; Traci LeMasters; Lianjie Xiong; Michael U Williams; Xi Tan
Journal:  Cardiovasc Drugs Ther       Date:  2018-12       Impact factor: 3.727

3.  Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery.

Authors:  Tomoki Takase; Hiroaki Ikesue; Makiko Tohi; Hiroshi Ueta; Hiroyuki Mima; Tadaaki Koyama; Tohru Hashida
Journal:  J Pharm Health Care Sci       Date:  2018-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.